Latest Capital Markets News

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.

Centuria Industrial REIT has secured a landmark 10-year lease with Tesla, delivering a 133% re-leasing spread and deferring redevelopment plans, while pursuing a major data centre expansion in Victoria.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.

L1 Group has appointed Julian Russell as its new CEO and Managing Director, marking a strategic leadership transition aimed at capitalising on growth opportunities. Russell’s proven track record in financial services turnaround sets the stage for renewed momentum.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

INOVIQ Limited has raised $9.5 million to advance its pioneering ovarian cancer screening test and CAR-exosome therapeutic programs, backed by strong preclinical data and strategic partnerships.

Elevra Lithium has completed a transformative merger and maintained robust production at its North American Lithium operation, while unveiling a compelling expansion plan that could boost output by 55% and slash costs.

Godolphin Resources has reported a substantial upgrade to its Lewis Ponds gold, silver, and base metals resource, alongside successful capital raising to fund ongoing development and exploration.

Tesoro Gold Limited has announced plans for a 15-for-1 share consolidation aimed at simplifying its capital structure and enhancing its appeal to investors, pending shareholder approval at the November 26 meeting.